VWWMG
RMD icon

Vermillion & White Wealth Management Group’s ResMed RMD Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24
Closed -$5.78K – 416
2025
Q4 		$5.78K Hold
24
– – ﹤0.01% 386
2025
Q3 		$6.57K Buy
+24
New +$6.56K ﹤0.01% 374

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vermillion & White Wealth Management Group's RMD Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 24 shares — an estimated $5.78K sold.

Vermillion & White Wealth Management Group first reported a position in RMD in Q3 2025 and held it in 2 quarters. The position peaked at $6.57K in Q3 2025. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 24 ResMed shares in Q1 2026, an estimated $5.78K.
  • Vermillion & White Wealth Management Group first reported a position in ResMed in Q3 2025 and held it in 2 quarters.
  • Vermillion & White Wealth Management Group's ResMed position peaked at $6.57K in Q3 2025.
  • 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.